UChicago Medicine · Decision guide
Chicago, United States · Totally endoscopic CABG, including selected multivessel and hybrid plans
UChicago’s robotic cardiac programme is led by Husam Balkhy and specifically describes totally endoscopic beating-heart CABG. Its published experience includes bypass to several vessels and hybrid treatment combining bypass with stents.
TECAB places bypass grafts through ports; the official profile identifies beating-heart TECAB as a principal technique.
Sources: Husam H. Balkhy, MD
In the 2013–2020 series, 56% had multivessel TECAB, with one conversion to sternotomy and reported mortality of 0.9%.
Early patency was 97% in assessed patients receiving hybrid revascularization.
Personal operations · Cumulative by September 2024; start unspecified · published 2024-09-19 · counting date 2024-09-19
Minimally invasive robot-assisted cardiac procedures across CABG, valves, ablation and congenital defects.
Former US attorney general chooses UChicago Medicine for robotic heart surgery ↗ · source read 2026-10-08Programme operations · Cumulative; counting cutoff not stated
Totally endoscopic coronary bypass using a robot and small chest ports. The hospital attributes this count to its surgical programme.
UChicago Medicine: totally endoscopic coronary bypass programme ↗ · source read 2026-10-08Your diagnosis, selected specialist and treatment priorities.
Sources: Husam H. Balkhy, MD · Robotic off-pump totally endoscopic coronary artery bypass in the current era: report of 544 patients.
Sources: Husam H. Balkhy, MD · Robotic off-pump totally endoscopic coronary artery bypass in the current era: report of 544 patients.
Chicago · United States
cardiac surgeon
Husam Balkhy leads robotic cardiac surgery at UChicago Medicine. His named CABG technique is totally endoscopic beating-heart bypass, including selected multivessel and hybrid procedures.
Sources: Husam H. Balkhy, MD · Robotic off-pump totally endoscopic coronary artery bypass in the current era: report of 544 patients.
Read alongside Husam H. Balkhy’s profile →
Balkhy was first author of the retrospective 2013–2020 series: 56% underwent multivessel TECAB, one case converted to sternotomy and reported mortality was 0.9%. Early graft patency was 97% in the assessed hybrid-revascularization patients.
How to interpret this: Single-centre selected cohort, mean STS risk 1.7%; patency was assessed in a subgroup. These are historical programme results, not a guarantee or a current personal success rate.
Continue your guide
Free Bookimed support. Compare options before deciding.
Your diagnosis, selected specialist and treatment priorities.
